These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6839006)

  • 1. Kinetics of cocaine in humans after intravenous and intranasal administration.
    Javaid JI; Musa MN; Fischman M; Schuster CR; Davis JM
    Biopharm Drug Dispos; 1983; 4(1):9-18. PubMed ID: 6839006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal and oral cocaine kinetics.
    Wilkinson P; Van Dyke C; Jatlow P; Barash P; Byck R
    Clin Pharmacol Ther; 1980 Mar; 27(3):386-94. PubMed ID: 7357795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct transport of cocaine from the nasal cavity to the brain following intranasal cocaine administration in rats.
    Chow HS; Chen Z; Matsuura GT
    J Pharm Sci; 1999 Aug; 88(8):754-8. PubMed ID: 10430537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cocaine plasma concentration: relation to physiological and subjective effects in humans.
    Javaid JI; Fischman MW; Schuster CR; Dekirmenjian H; Davis JM
    Science; 1978 Oct; 202(4364):227-8. PubMed ID: 694530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cocaine disposition in saliva following intravenous, intranasal, and smoked administration.
    Cone EJ; Oyler J; Darwin WD
    J Anal Toxicol; 1997 Oct; 21(6):465-75. PubMed ID: 9323527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic properties of ethosuximide in monkeys. I. Single-dose intravenous and oral administration.
    Patel IH; Levy RH; Bauer TG
    Epilepsia; 1975 Dec; 16(5):705-16. PubMed ID: 816644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cocaine disposition in humans after intravenous injection, nasal insufflation (snorting), or smoking.
    Jeffcoat AR; Perez-Reyes M; Hill JM; Sadler BM; Cook CE
    Drug Metab Dispos; 1989; 17(2):153-9. PubMed ID: 2565204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal cocaine in humans: acute tolerance, cardiovascular and subjective effects.
    Foltin RW; Haney M
    Pharmacol Biochem Behav; 2004 May; 78(1):93-101. PubMed ID: 15159138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct nose-brain transport of benzoylecgonine following intranasal administration in rats.
    Chow HH; Anavy N; Villalobos A
    J Pharm Sci; 2001 Nov; 90(11):1729-35. PubMed ID: 11745730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular effects and detection in tears of aerosolized intranasal cocaine and fluorescein.
    Orlick ME; Kastl PR; Donzis PB; Howard R; Rice J; Tauber S
    Ann Ophthalmol; 1990 Jul; 22(7):249-54. PubMed ID: 2393222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute systemic effects of cocaine in man: a controlled study by intranasal and intravenous routes.
    Resnick RB; Kestenbaum RS; Schwartz LK
    Science; 1977 Feb; 195(4279):696-8. PubMed ID: 841307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of route of administration on cocaine induced dopamine transporter blockade in the human brain.
    Volkow ND; Wang GJ; Fischman MW; Foltin R; Fowler JS; Franceschi D; Franceschi M; Logan J; Gatley SJ; Wong C; Ding YS; Hitzemann R; Pappas N
    Life Sci; 2000 Aug; 67(12):1507-15. PubMed ID: 10983846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma levels following intranasal and intravenous administration of human interferon-beta to rabbits.
    Maitani Y; Igawa T; Machida Y; Nagai T
    Drug Des Deliv; 1989 Mar; 4(2):109-19. PubMed ID: 2765103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The bioavailability of intranasal lignocaine.
    Scavone JM; Greenblatt DJ; Fraser DG
    Br J Clin Pharmacol; 1989 Dec; 28(6):722-4. PubMed ID: 2611092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of cocaine distribution, elimination, and chronotropic effects.
    Chow MJ; Ambre JJ; Ruo TI; Atkinson AJ; Bowsher DJ; Fischman MW
    Clin Pharmacol Ther; 1985 Sep; 38(3):318-24. PubMed ID: 4028628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cocaine pharmacokinetics in humans.
    Barnett G; Hawks R; Resnick R
    J Ethnopharmacol; 1981; 3(2-3):353-66. PubMed ID: 7242115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of meclizine levels in the plasma of rats and dogs after intranasal, intravenous, and oral administration.
    Chovan JP; Klett RP; Rakieten N
    J Pharm Sci; 1985 Oct; 74(10):1111-3. PubMed ID: 4078711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of intranasal versus intravenous fentanyl in patients with pain after oral surgery.
    Foster D; Upton R; Christrup L; Popper L
    Ann Pharmacother; 2008 Oct; 42(10):1380-7. PubMed ID: 18728103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of cocaine.
    Cone EJ
    J Anal Toxicol; 1995 Oct; 19(6):459-78. PubMed ID: 8926741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urine testing for cocaine abuse: metabolic and excretion patterns following different routes of administration and methods for detection of false-negative results.
    Cone EJ; Sampson-Cone AH; Darwin WD; Huestis MA; Oyler JM
    J Anal Toxicol; 2003 Oct; 27(7):386-401. PubMed ID: 14606991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.